Alcami Executive and Leadership Team

Roz Stone, the Earthware Enterprise Chief Executive Officer at Alcami, directs the overarching strategic vision for the organization. By aligning corporate objectives with the evolving needs of the pharmaceutical and biotech sectors, Stone ensures the company maintains a competitive edge in contract development and manufacturing. This leadership role involves constant engagement with the Board to secure long-term growth and operational excellence across all United States facilities. Roz Stone architects high-level initiatives that prioritize innovation in sterile and oral solid manufacturing. Through rigorous oversight of the development lifecycle, the Chief Executive Officer fosters a culture of quality and compliance. By championing advanced analytical development and cGMP biostorage capabilities, the executive drives the company toward sustainable market expansion. Ultimately, Stone secures the financial health and operational integrity of the entire enterprise while supporting the complex requirements of global pharmaceutical partners.

Guy Kubi, the Chief Operating Officer at Alcami, manages the daily execution of manufacturing and packaging operations across the 675,000 square feet of facility space. Overseeing the integration of clinical and commercial production lines, the Chief Operating Officer ensures that all processes meet stringent cGMP standards. Guy Kubi optimizes supply chain logistics and environmental monitoring protocols to maintain seamless service delivery for pharmaceutical clients. This role requires constant coordination with site leaders to maximize efficiency and throughput in sterile and oral solid manufacturing. By implementing lean manufacturing principles, Kubi reduces operational bottlenecks and enhances output quality. The Chief Operating Officer monitors performance metrics to guarantee that every project adheres to strict timelines and regulatory requirements. Through this focus on operational excellence, Kubi supports the company mission of providing innovative, reliable solutions for biotech companies of all sizes throughout the North American market.

Tori Arens, the President, Drug Product at Alcami, leads the strategic direction for sterile and oral solid manufacturing services. Overseeing the transition of products from clinical stages to commercial scale, the President, Drug Product ensures that all manufacturing processes adhere to the highest quality standards. Tori Arens manages the technical teams responsible for packaging and pharmaceutical support services, ensuring alignment with client specifications and regulatory mandates. This role involves close collaboration with the laboratory operations team to facilitate seamless product development. By driving innovation in manufacturing technologies, Arens enhances the service offerings available to pharmaceutical and biotech partners. The President, Drug Product monitors market trends to identify opportunities for expanding the company footprint in the drug product sector. Through rigorous project management and technical oversight, Arens ensures that the organization delivers consistent, high-quality results that support the development lifecycle of critical medical products.

Katie Schlipp, the President, Laboratory Operations at Alcami, directs the analytical development, microbiology, and environmental monitoring functions that underpin the company service portfolio. Overseeing the technical staff, the President, Laboratory Operations ensures that all testing and validation processes meet the rigorous demands of the pharmaceutical industry. Katie Schlipp manages the integration of laboratory data with manufacturing workflows to provide comprehensive support for biotech clients. This role involves maintaining state-of-the-art laboratory infrastructure and ensuring compliance with cGMP biostorage protocols. By optimizing testing methodologies, Schlipp improves the speed and accuracy of product development cycles. The President, Laboratory Operations collaborates with the drug product leadership to ensure that analytical insights inform manufacturing decisions. Through this focus on scientific excellence, Schlipp supports the company commitment to providing innovative solutions that advance products through every stage of the development lifecycle, ultimately ensuring the safety and efficacy of client drug portfolios.

Rose-Marie Nelson, the Chief Human Resources Officer at Alcami, designs and executes the talent acquisition and organizational development strategies necessary to support a workforce of technical experts. By fostering a culture of safety, compliance, and innovation, the Chief Human Resources Officer ensures that the company attracts and retains top-tier professionals in the pharmaceutical manufacturing space. Rose-Marie Nelson oversees the implementation of training programs that align with cGMP requirements and operational standards. This leadership role involves managing employee relations and performance management systems to drive productivity across all regional sites. By optimizing human capital, Nelson directly impacts the ability of the organization to deliver high-quality analytical development and microbiology services. The Chief Human Resources Officer collaborates with other C-suite leaders to ensure that organizational structure supports the long-term growth objectives of the business. Through these efforts, Nelson maintains a high-performing environment that consistently meets the complex demands of the biotech industry.